Atlantic Biopharmaceuticals

Atlantic Biopharmaceuticals is a biopharmaceutical company based in Xiamen, China, specializing in the development and commercialization of high-quality biologics and biosimilars. The company focuses on therapeutic areas such as oncology, ophthalmology, and autoimmune diseases, leveraging its large-scale mammalian cell culture and purification capabilities. Its lead products include biosimilars for major blockbuster drugs like bevacizumab and adalimumab, aimed at increasing patient access to critical therapies in emerging markets. Atlantic Biopharmaceuticals operates integrated R&D and manufacturing facilities that comply with international GMP standards.